On Monday, Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA), gained 2.88% to $84.89.
Walgreens Boots Alliance, declared it has accomplished the placement of $5 billion of term loan facilities, evenly split between two tranches of $2.5 billion each, with three- and five-year maturities, respectively, and a $7.8 billion term loan bridge facility. These facilities replace the company’s formerly stated $12.8 billion bridge facility commitment.
This financing has been put in place as part of the financing of Walgreens Boots Alliance’s projected acquisition of Rite Aid Corporation (RAD). Drawing under the facilities is subject to the closing of this acquisition.
“The term loan facilities constitute a key milestone in securing permanent financing for the projected acquisition of Rite Aid,” said George Fairweather, Executive Vice President and Global Chief Financial Officer of Walgreens Boots Alliance, Inc. “We are very happy with the high level of interest and support from our banking partners, which resulted in the oversubscription of the transaction. The $5 billion pre-payable term facilities provide us with diversification of funding sources and the flexibility to reduce leverage over time.”
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.
Shares of Arena Pharmaceuticals, Inc (NASDAQ:ARNA), inclined 6.84% to $2.03, during its last trading session.
Park Lane Advisor has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (ARNA), Cara Therapeutics Inc. (CARA), Corcept Therapeutics Inc. (CORT), and Ignyta Inc. (RXDX). Free research report on Arena Pharma can be accessed at http://www.parklaneadvisor.com/ On Friday, December 18, 2015, the NASDAQ Composite ended at 4,923.08, down 1.59%, the Dow Jones Industrial Average declined 2.10%, to finish the day at 17,128.55, and the S&P 500 closed at 2,005.55, down 1.78%. The losses were broad based as all the sectors ended the session in negative. Register for your complimentary reports at the links given below.
On Friday, shares in Arena Pharmaceuticals Inc. ended the session 3.83% higher at $1.90. The stock stated a trading volume of 15.30 million shares, much above to its three months average volume of 3.26 million shares. Arena Pharmaceuticals Inc.’s shares have declined 5.00% in the last one month, 27.20% in the previous three months and 45.24% on YTD basis. The company is trading 7.55% below its 50-day moving average and 44.61% below its 200-day moving average. Moreover, shares of Arena Pharmaceuticals Inc. have a Relative Strength Index (RSI) of 46.54.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases.
Finally, Windstream Holdings, Inc. (NASDAQ:WIN), ended its last trade with 2.22% loss, and closed at $6.45.
Windstream, declared it has accomplished the sale of its data center business to TierPoint in an all-cash transaction valued at $575 million.
Originally declared on October 19, the transaction comprises an ongoing, reciprocal planned partnership allowing each company to sell its products and services to the other’s prospective customers.
“This transaction enables Wind stream to focus capital on our core telecom offerings and pay down debt, while providing expanded data center services to our enterprise customers,” said Tony Thomas, Wind stream’s president and CEO. “We expect the divested data center business to continue its growth under our new partnership.”
Wind stream Holdings, Inc. provides communications and technology solutions in the United States. It offers managed services and cloud computing services to businesses, in addition to broadband, voice, and video services to consumers primarily in rural markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.